CRX-526

N/A

Report date: 2023/05/22 10:16:34
NME

Base Information

Drug NameCRX-526
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionToll like receptor 4 antagonists
TargetsToll like receptor 4
Therapy Area/IndicationsReperfusion Injury
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesX-in8 Biologicals Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesX-in8 Biologicals CorpUniversity Of North Carolina At Chapel Hill
Active IndicationsN/A
Inactive IndicationsReperfusion Injury

Other Information

ATC CodeN/A
Related LinksN/A